Acamprosate Calcium Articles
Forest Labs' sales hit by Celexa competition
25 April 2005
Forest's Campral is safe and well-tolerated
25 April 2005
Forest launch Campral in the USA
24 January 2005
Merck KGaA's 3rd-qtr profit leaps 43%
1 November 2004
FDA clears Merck KGaA/Forest's Campral
9 August 2004
Fast-track review for Merck/Forest's Campral
11 March 2002
Forest to sell Merck's addiction drug in USA
31 October 2001
Merck UK DTC ads target alcohol
11 January 2001
Modernizing Merck KGaA looking to long-term growth from pharma
8 November 2000
Merck KGaA to reveal late-stage news soon
20 June 2000
Merck KGaA Expecting Strong Sales Growth
30 June 1998
Lipha US Sales Match Drug Turnover In France
21 March 1997
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
Acamprosate - An Integrative Therapy for Alcoholism
15 July 1996
New Insights Into Alcohol Abuse
22 April 1996
Merck KGaA: Campral approvals
15 January 1996
Merck KGaA's Alcoholism drug
20 November 1995
Merck's IPO Expected To Raise Up To 2.5 Bill Marks
2 October 1995
Acamprosate UK Application Filed
20 March 1995
Showing 1-23 of 23 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
